{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:30:59Z","timestamp":1774434659729,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clnesp.2025.11.159","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:59:15Z","timestamp":1764662355000},"page":"102839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Myostatin, activin-A and follistatin are produced by the tumor in head and neck cancer and likely contribute to sarcopenia: A case-control, cross-sectional exploratory study"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-2010","authenticated-orcid":false,"given":"Nicolas","family":"Saroul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Dissard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-7161","authenticated-orcid":false,"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Mom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3999-1599","authenticated-orcid":false,"given":"Yves","family":"Boirie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Gilain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Puechmaille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Patrac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1787-5802","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Walrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2025.11.159_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clnesp.2025.11.159_bib2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0194599818755995","article-title":"Which assessment method of malnutrition in head and neck cancer? Otolaryngol--Head neck surg off","volume":"158","author":"Saroul","year":"2018","journal-title":"J Am Acad Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clnesp.2025.11.159_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hed.20447","article-title":"Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment","volume":"29","author":"Couch","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.clnesp.2025.11.159_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2","article-title":"Proceedings: causes of death in cancer patients","volume":"33","author":"Inagaki","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.clnesp.2025.11.159_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ando.2013.03.004","article-title":"[Role of activin A and myostatin in cancer cachexia]","volume":"74","author":"Thissen","year":"2013","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib7","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10585-006-9010-5","article-title":"Activin A circulating levels in patients with bone metastasis from breast or prostate cancer","volume":"23","author":"Leto","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.clnesp.2025.11.159_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/eje.0.1450225","article-title":"Expression and secretion of activin A: possible physiological and clinical implications","volume":"145","author":"Luisi","year":"2001","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"10.1016\/j.clnesp.2025.11.159_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clnesp.2025.11.159_bib11","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","article-title":"Myostatin gene inactivation prevents skeletal muscle wasting in cancer","volume":"74","author":"Gallot","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.clnesp.2025.11.159_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Costelli","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clnesp.2025.11.159_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080454","article-title":"Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients","volume":"8","author":"Breitbart","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2025.11.159_bib14","first-page":"8","article-title":"Myostatin expression in age and denervation-induced skeletal muscle atrophy","volume":"3","author":"Baumann","year":"2003","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.clnesp.2025.11.159_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/iub.1392","article-title":"Myostatin: expanding horizons","volume":"67","author":"Sharma","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.clnesp.2025.11.159_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.23798","article-title":"Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patients","volume":"48","author":"Bonetto","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clnesp.2025.11.159_bib17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1245\/s10434-011-1720-5","article-title":"Changes in myostatin signaling in non-weight-losing cancer patients","volume":"19","author":"Aversa","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib18","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of activin A and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2025.11.159_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1016\/j.clnesp.2025.11.159_bib20","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ageing\/afu115","article-title":"Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS)","volume":"43","author":"Cruz-Jentoft","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2025.11.159_bib21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0898264312438551","article-title":"Validity and reliability of the short physical performance battery in two diverse older adult populations in Quebec and Brazil","volume":"24","author":"Freire","year":"2012","journal-title":"J Aging Health"},{"key":"10.1016\/j.clnesp.2025.11.159_bib22","first-page":"357","article-title":"Body composition measurements during wasting diseases","volume":"1","author":"Pichard","year":"1998","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnesp.2025.11.159_bib23","first-page":"1356","article-title":"Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry","volume":"36","author":"Jackson","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.clnesp.2025.11.159_bib24","first-page":"248","article-title":"Single prediction equation for bioelectrical impedance analysis in adults aged 20--94 years","volume":"17","author":"Kyle","year":"2001","journal-title":"Nutr Burbank Los Angel Cty Calif"},{"key":"10.1016\/j.clnesp.2025.11.159_bib25","first-page":"465","article-title":"Estimation of skeletal muscle mass by bioelectrical impedance analysis","volume":"89","author":"Janssen","year":"2000","journal-title":"J Appl Physiol Bethesda Md 1985"},{"key":"10.1016\/j.clnesp.2025.11.159_bib26","doi-asserted-by":"crossref","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.11.159_bib27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab Physiol Appl Nutr Metab"},{"key":"10.1016\/j.clnesp.2025.11.159_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/sj.ijo.0801921","article-title":"A novel method of measuring intra-abdominal fat volume using helical computed tomography","volume":"26","author":"Kobayashi","year":"2002","journal-title":"Int J Obes Relat Metab Disord J Int Assoc Study Obes"},{"key":"10.1016\/j.clnesp.2025.11.159_bib29","first-page":"115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1998","journal-title":"J Appl Physiol Bethesda Md 1985"},{"key":"10.1016\/j.clnesp.2025.11.159_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2015.09.001","article-title":"Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes","volume":"54","author":"Kazemi-Bajestani","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib31","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/sj.bjc.6601373","article-title":"Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)","volume":"89","author":"Lemaire","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnesp.2025.11.159_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.6004\/jnccn.2025.0007","article-title":"NCCN guidelines\u00ae insights: head and neck cancers, version 2.2025","volume":"23","author":"Colevas","year":"2025","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.clnesp.2025.11.159_bib33","doi-asserted-by":"crossref","first-page":"880419","DOI":"10.3389\/fonc.2022.880419","article-title":"Nutritional risk index as a prognostic factor predicts the clinical outcomes in patients with stage III gastric cancer","volume":"12","author":"Song","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib34","doi-asserted-by":"crossref","first-page":"1399957","DOI":"10.3389\/fonc.2024.1399957","article-title":"Geriatric nutritional risk index and mortality from all-cause, cancer, and non-cancer in US cancer survivors: NHANES 2001-2018","volume":"14","author":"Qiu","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib35","first-page":"2045","article-title":"Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis","volume":"39","author":"Rinninella","year":"2020","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1016\/j.clnesp.2025.11.159_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijom.2024.07.008","article-title":"The prognostic value of pre-treatment sarcopenia in overall survival in head and neck cancer patients: a systematic review","volume":"54","author":"Syziu","year":"2025","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.clnesp.2025.11.159_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.anorl.2019.12.005","article-title":"Impact of nutritional status at the outset of assessment on postoperative complications in head and neck cancer","volume":"137","author":"Caburet","year":"2020","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.clnesp.2025.11.159_bib38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hed.26954","article-title":"Toxicity of induction chemotherapy in head and neck cancer: the central role of skeletal muscle mass","volume":"44","author":"Lere-Chevaleyre","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.clnesp.2025.11.159_bib39","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/annonc\/mds068","article-title":"Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy","volume":"23","author":"Terpos","year":"2012","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"10.1016\/j.clnesp.2025.11.159_bib40","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7796","article-title":"High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma","author":"Hoda","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clnesp.2025.11.159_bib41","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/j.cllc.2019.10.013","article-title":"Elevated circulating activin A levels in patients with malignant pleural mesothelioma are related to cancer cachexia and reduced response to platinum-based chemotherapy","volume":"21","author":"Paajanen","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.clnesp.2025.11.159_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1999.5417","article-title":"Secretion of activin A in recurrent epithelial ovarian carcinoma","volume":"74","author":"Lambert-Messerlian","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib43","first-page":"4371","article-title":"Activin A as a novel biomarker for colorectal adenocarcinoma in humans","volume":"19","author":"Wu","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clnesp.2025.11.159_bib44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/147323001204000306","article-title":"High serum levels of follistatin in patients with ovarian cancer","volume":"40","author":"Ren","year":"2012","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clnesp.2025.11.159_bib45","article-title":"Follistatin is a novel biomarker for lung adenocarcinoma in humans","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2025.11.159_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cytogfr.2013.03.003","article-title":"The activins and their binding protein, follistatin-diagnostic and therapeutic targets in inflammatory disease and fibrosis","volume":"24","author":"Hedger","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.clnesp.2025.11.159_bib47","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1073\/pnas.1916034117","article-title":"GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN\/GDF11 inhibitor, increases muscle mass but weakens bone","volume":"117","author":"Suh","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clnesp.2025.11.159_bib48","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1152\/ajpendo.00193.2009","article-title":"Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin","volume":"297","author":"Gilson","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2025.11.159_bib49","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of activin A and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2025.11.159_bib50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/mus.23945","article-title":"Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle","volume":"49","author":"D\u2019Orlando","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clnesp.2025.11.159_bib51","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3945\/ajcn.112.045708","article-title":"Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients","volume":"96","author":"Williams","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.11.159_bib52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1530\/eje.0.1480559","article-title":"Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia","volume":"148","author":"Michel","year":"2003","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"10.1016\/j.clnesp.2025.11.159_bib53","doi-asserted-by":"crossref","first-page":"16239","DOI":"10.1073\/pnas.0705971104","article-title":"Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia","volume":"104","author":"Jones","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clnesp.2025.11.159_bib54","first-page":"140","article-title":"Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases","volume":"21","author":"Sacheck","year":"2007","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077119","article-title":"Follistatin is induced by ionizing radiation and potentially predictive of radiosensitivity in radiation-induced fibrosis patient derived fibroblasts","volume":"8","author":"Forrester","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2025.11.159_bib56","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0505996102","article-title":"Regulation of muscle growth by multiple ligands signaling through activin type II receptors","volume":"102","author":"Lee","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clnesp.2025.11.159_bib57","first-page":"1653","article-title":"Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease","volume":"25","author":"Zhang","year":"2011","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"10.1016\/j.clnesp.2025.11.159_bib58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.clnesp.2025.11.159_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13539-011-0049-z","article-title":"Myostatin blockage using actRIIB antagonism in mice bearing the lewis lung carcinoma results in the improvement of muscle wasting and physical performance","volume":"3","author":"Busquets","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2025.11.159_bib60","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clnesp.2025.11.159_bib61","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/SPC.0000000000000013","article-title":"Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders","volume":"7","author":"Smith","year":"2013","journal-title":"Curr Opin Support Palliat Care"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725031535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725031535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T21:33:11Z","timestamp":1768944791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725031535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":61,"alternative-id":["S2405457725031535"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.11.159","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myostatin, activin-A and follistatin are produced by the tumor in head and neck cancer and likely contribute to sarcopenia: A case-control, cross-sectional exploratory study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.11.159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}],"article-number":"102839"}}